150 related articles for article (PubMed ID: 37359941)
1. Updated Incidence, Treatment and Survival of a Nationwide Cohort of Patients with Peritoneal Metastases of Unknown Origin.
Rijken A; Loef C; van de Wouw YAJ; van Erning FN; de Hingh IHJT
Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):67-73. PubMed ID: 37359941
[TBL] [Abstract][Full Text] [Related]
2. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.
Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH
Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935
[TBL] [Abstract][Full Text] [Related]
3. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.
Rijken A; Bakkers C; Klümpen HJ; van der Geest LG; de Vos-Geelen J; van Erning FN; de Hingh IHJT
Eur J Surg Oncol; 2023 Aug; 49(8):1436-1443. PubMed ID: 36898900
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal Metastases from Extraperitoneal Primary Tumors: Incidence, Treatment, and Survival from a Nationwide Database.
Rijken A; Galanos LJK; Burger JWA; Nienhuijs SW; van Erning FN; de Hingh IHJT
Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):60-66. PubMed ID: 37359924
[TBL] [Abstract][Full Text] [Related]
6. Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort.
Koemans WJ; Lurvink RJ; Grootscholten C; Verhoeven RHA; de Hingh IH; van Sandick JW
Gastric Cancer; 2021 Jul; 24(4):800-809. PubMed ID: 33495964
[TBL] [Abstract][Full Text] [Related]
7. Incidence, risk factors, treatment, and survival of ovarian metastases of colorectal origin: a Dutch population-based study.
Bakkers C; van der Meer R; Roumen RM; Lurvink RJ; Lemmens VE; van Erning FN; de Hingh IH
Int J Colorectal Dis; 2020 Jun; 35(6):1035-1044. PubMed ID: 32157379
[TBL] [Abstract][Full Text] [Related]
8. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN
Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797
[TBL] [Abstract][Full Text] [Related]
10. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
[TBL] [Abstract][Full Text] [Related]
11. Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases.
Simkens GA; Razenberg LG; Lemmens VE; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2016 Jun; 42(6):794-800. PubMed ID: 27055946
[TBL] [Abstract][Full Text] [Related]
12. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site-a Review.
Bhatt A; Mishra S; Glehen O
Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):15-29. PubMed ID: 37359927
[TBL] [Abstract][Full Text] [Related]
13. Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study.
Lurvink RJ; Rijken A; Bakkers C; Aarts MJ; Kunst PWA; van de Borne BE; van Erning FN; de Hingh IHJT
Clin Exp Metastasis; 2021 Jun; 38(3):295-303. PubMed ID: 33738641
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands.
Burg L; Timmermans M; van der Aa M; Boll D; Rovers K; de Hingh I; van Altena A
J Gynecol Oncol; 2020 Sep; 31(5):e58. PubMed ID: 32808491
[TBL] [Abstract][Full Text] [Related]
15. A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer.
de Boer NL; Rovers K; Burger JWA; Madsen EVE; Brandt-Kerkhof ARM; Kok NFM; de Wilt JHW; de Reuver PH; Bos A; de Hingh IHJT; Verhoef C
Cancer Med; 2020 Aug; 9(16):5851-5859. PubMed ID: 32614506
[TBL] [Abstract][Full Text] [Related]
16. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
[TBL] [Abstract][Full Text] [Related]
17. Site-specific survival rates for cancer of unknown primary according to location of metastases.
Hemminki K; Riihimäki M; Sundquist K; Hemminki A
Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
[TBL] [Abstract][Full Text] [Related]
18. The prognostic relevance of histologic subtype in appendiceal adenocarcinoma.
Legué LM; van Erning FN; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
Eur J Surg Oncol; 2020 Mar; 46(3):433-438. PubMed ID: 31668980
[TBL] [Abstract][Full Text] [Related]
19. Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study.
Rijken A; van de Vlasakker VCJ; Simkens GA; Rovers KP; van Erning FN; Koopman M; Verhoef C; de Wilt JHW; de Hingh IHJT
Clin Exp Metastasis; 2023 Aug; 40(4):289-298. PubMed ID: 37209222
[TBL] [Abstract][Full Text] [Related]
20. Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012.
Schroten-Loef C; Verhoeven RHA; de Hingh IHJT; van de Wouw AJ; van Laarhoven HWM; Lemmens VEPP
Eur J Cancer; 2018 Sep; 101():77-86. PubMed ID: 30031970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
